Lynette Herscha

Chief Operating Officer at

Immunitas Therapeutics, Inc.

54 year

Health Technology

Consumer Services

Profile

Lynette Herscha is currently the Chief Operating Officer at Immunitas Therapeutics, Inc. She previously worked as the Secretary & General Counsel at Concert Pharmaceuticals, Inc. from 2017 to 2019.
She also held the position of Secretary & Chief Legal Officer at Solid Biosciences, Inc. Ms. Herscha received her undergraduate degree from Boston University and her graduate degree from Boston University School of Law.

Lynette Herscha active positions

Companies	Position	Start
Immunitas Therapeutics, Inc. Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs	Chief Operating Officer	13/07/2022

All active positions of Lynette Herscha

Former positions of Lynette Herscha

Companies	Position	End
CONCERT PHARMACEUTICALS, INC.	General Counsel	01/01/2019
SOLID BIOSCIENCES INC.	General Counsel	-

See the detail of Lynette Herscha's experience

Training of Lynette Herscha

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lynette Herscha's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Concert Pharmaceuticals, Inc. Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Boston University School of Law Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Solid Biosciences, Inc. Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease	Health Technology
Immunitas Therapeutics, Inc. Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs	Health Technology